Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas
LoG-Glio
1 other identifier
observational
300
1 country
1
Brief Summary
The LoG-Glio-Registry is based on a network of german hospitals gathering radiological, clinical, epidemiological and molecular data on all patients diagnosed with a low grade glioma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2015
CompletedFirst Submitted
Initial submission to the registry
February 4, 2016
CompletedFirst Posted
Study publicly available on registry
February 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2036
May 11, 2023
May 1, 2023
11.1 years
February 4, 2016
May 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Progression-free survival (PFS)
5yrs
Overall survival (OS)
15yrs
Secondary Outcomes (2)
Extent of tumor resection
3yrs
Quality of life (QoL) assessed by the EORTC QLQ C-30/BN-20. (European Organisation for Research and Treatment of Cancer Quality of Life Questionaire C-30
5yrs
Interventions
Eligibility Criteria
All adult patients with radiological suspected diagnosis of a low grade glioma
You may qualify if:
- Patients with radiological suspected diagnosis of a low grade glioma
- Age ≥ 18 years. There is no upper age limit.
You may not qualify if:
- Severe neurological or psychiatric disorder interfering with ability to give an informed consent
- No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation
- No consent for bio-banking of patient's biological specimens and performance of analyses on stored material.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Ulmlead
- Charite University, Berlin, Germanycollaborator
Study Sites (1)
University of Ulm
Ulm, Germany
Related Publications (1)
Pala A, Nadji-Ohl M, Faust K, Ruckriegel S, Roder C, von der Brelie C, Forster MT, Lobel F, Schommer S, Lohr M, Renovanz M, Grubel N, Rothenbacher D, Konig R, Engelke J, Schmitz B, Wirtz CR, Ringel F, Senft C, Rohde V, Tatagiba M, Ernestus RI, Vajkoczy P, Ganslandt O, Nagel G, Coburger J. Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio Project. J Neurol Surg A Cent Eur Neurosurg. 2020 Jan;81(1):48-57. doi: 10.1055/s-0039-1693650. Epub 2019 Sep 24.
PMID: 31550737DERIVED
Biospecimen
Blood and tumor samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
February 4, 2016
First Posted
February 19, 2016
Study Start
November 15, 2015
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 1, 2036
Last Updated
May 11, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share